z-logo
open-access-imgOpen Access
Cyclin-dependent kinase 1 inhibitor RO3306 promotes mitotic slippage in paclitaxel-treated HepG2 cells
Author(s) -
Jinfeng Xiao,
Peihuan Qiu,
Xiulan Lai,
Peiyan He,
Yan Wu,
Dirk U. Bellstedt,
Yuwei Tan
Publication year - 2013
Publication title -
neoplasma
Language(s) - Slovenian
Resource type - Journals
SCImago Journal Rank - 0.628
H-Index - 50
eISSN - 1338-4317
pISSN - 0028-2685
DOI - 10.4149/neo_2014_007
Subject(s) - cell cycle , cyclin b1 , cancer research , paclitaxel , cell growth , apoptosis , mtt assay , flow cytometry , hepatocellular carcinoma , cyclin , chemistry , mitosis , viability assay , biology , cyclin dependent kinase 1 , microbiology and biotechnology , cancer , medicine , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom